Nuvectis licenses two clinical-stage compounds from Haisco
Go back to Nuvectis licenses two clinical-stage compounds from Haisco| (NASDAQ: NVCT) | Delayed: 22.00 +0.62 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.38 | 52 Week High | $ | |||
| Open | $21.27 | 52 Week Low | $ | |||
| Day High | $23.00 | P/E | N/A | |||
| Day Low | $21.06 | EPS | $ | |||
| Volume | 722,686 | |||||
